|
Caribou Biosciences ، Inc. (CRBU) DCF تقييم
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Caribou Biosciences, Inc. (CRBU) Bundle
تبحث لتقييم القيمة الجوهرية لـ Caribou Biosciences ، Inc.؟ يدمج حاسبة DCF (CRBU) DCF بيانات العالم الحقيقي مع خيارات تخصيص واسعة ، مما يتيح لك ضبط التنبؤات وتعزيز قرارات الاستثمار الخاصة بك.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.8 | 12.4 | 9.6 | 13.9 | 34.5 | 53.6 | 83.4 | 129.6 | 201.5 | 313.4 |
| Revenue Growth, % | 0 | 113.56 | -22.35 | 44.31 | 148.91 | 55.49 | 55.49 | 55.49 | 55.49 | 55.49 |
| EBITDA | -30.2 | -35.2 | -66.0 | -104.8 | -112.5 | -53.6 | -83.4 | -129.6 | -201.5 | -313.4 |
| EBITDA, % | -521.99 | -284.82 | -687.59 | -756.46 | -326.4 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | .8 | .9 | 1.0 | 3.6 | 3.5 | 7.2 | 11.2 | 17.4 | 27.0 | 42.0 |
| Depreciation, % | 12.98 | 7.28 | 10.25 | 26.29 | 10.22 | 13.4 | 13.4 | 13.4 | 13.4 | 13.4 |
| EBIT | -31.0 | -36.1 | -67.0 | -108.4 | -116.1 | -53.6 | -83.4 | -129.6 | -201.5 | -313.4 |
| EBIT, % | -534.97 | -292.1 | -697.84 | -782.74 | -336.63 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 49.5 | 16.0 | 413.5 | 317.0 | 328.8 | 53.6 | 83.4 | 129.6 | 201.5 | 313.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 4.0 | 5.2 | 8.1 | 4.7 | 3.9 | 25.7 | 40.0 | 62.2 | 96.8 | 150.4 |
| Account Receivables, % | 68.8 | 41.74 | 84.64 | 33.67 | 11.19 | 48.01 | 48.01 | 48.01 | 48.01 | 48.01 |
| Inventories | 3.2 | 2.4 | -31.1 | -62.6 | .0 | -13.4 | -20.9 | -32.5 | -50.5 | -78.6 |
| Inventories, % | 54.98 | 19.68 | -324.14 | -451.74 | 0 | -25.07 | -25.07 | -25.07 | -25.07 | -25.07 |
| Accounts Payable | 2.5 | 2.6 | 4.0 | 1.1 | 3.1 | 13.3 | 20.6 | 32.1 | 49.9 | 77.6 |
| Accounts Payable, % | 43.83 | 21.04 | 41.57 | 8.27 | 9.05 | 24.75 | 24.75 | 24.75 | 24.75 | 24.75 |
| Capital Expenditure | -.9 | -1.3 | -3.1 | -7.1 | -11.6 | -15.3 | -23.8 | -37.1 | -57.7 | -89.6 |
| Capital Expenditure, % | -15.27 | -10.64 | -32.52 | -50.93 | -33.68 | -28.61 | -28.61 | -28.61 | -28.61 | -28.61 |
| Tax Rate, % | -0.18944 | -0.18944 | -0.18944 | -0.18944 | -0.18944 | -0.18944 | -0.18944 | -0.18944 | -0.18944 | -0.18944 |
| EBITAT | -23.4 | -34.3 | -67.3 | -108.5 | -116.3 | -50.5 | -78.5 | -122.0 | -189.7 | -294.9 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -28.2 | -35.1 | -37.5 | -79.8 | -184.2 | -56.9 | -90.6 | -140.9 | -219.0 | -340.6 |
| WACC, % | 12.11 | 12.29 | 12.34 | 12.34 | 12.34 | 12.29 | 12.29 | 12.29 | 12.29 | 12.29 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -550.6 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -347 | |||||||||
| Terminal Value | -3,377 | |||||||||
| Present Terminal Value | -1,892 | |||||||||
| Enterprise Value | -2,443 | |||||||||
| Net Debt | -24 | |||||||||
| Equity Value | -2,419 | |||||||||
| Diluted Shares Outstanding, MM | 74 | |||||||||
| Equity Value Per Share | -32.77 |
What You Will Get
- Real Caribou Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Caribou Biosciences, Inc. (CRBU).
- Full Customization: Adjust all critical parameters (yellow cells) such as WACC, growth %, and tax rates to fit your analysis.
- Instant Valuation Updates: Automatic recalculations to assess the impact of changes on Caribou’s fair value.
- Versatile Excel Template: Designed for quick edits, scenario testing, and comprehensive projections.
- Time-Saving and Accurate: Avoid building models from scratch while ensuring precision and flexibility in your analyses.
Key Features
- 🔍 Real-Life CRBU Financials: Pre-filled historical and projected data for Caribou Biosciences, Inc.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Caribou’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Caribou’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- 1. Access the Model: Download and open the Excel file containing Caribou Biosciences, Inc. (CRBU) data.
- 2. Adjust Key Inputs: Modify critical parameters such as growth projections, discount rates, and investment costs.
- 3. Analyze Results in Real-Time: The financial model automatically computes intrinsic value and net present value (NPV).
- 4. Explore Different Scenarios: Evaluate various forecasts to assess diverse valuation possibilities.
- 5. Present with Assurance: Deliver expert valuation findings to back your strategic decisions.
Why Choose This Calculator for Caribou Biosciences, Inc. (CRBU)?
- Comprehensive Tool: Integrates DCF, WACC, and financial ratio analyses tailored for biotech companies.
- Customizable Inputs: Modify highlighted cells to explore different financial scenarios.
- Detailed Insights: Automatically computes Caribou's intrinsic value and Net Present Value.
- Preloaded Data: Historical and projected data provide reliable foundations for analysis.
- Professional Quality: Perfect for biotech analysts, investors, and business strategists.
Who Should Use This Product?
- Biotechnology Students: Explore gene editing techniques and apply them using real-world case studies.
- Researchers: Integrate advanced CRISPR models into your studies or publications.
- Investors: Evaluate your investment strategies and analyze market trends for Caribou Biosciences, Inc. (CRBU).
- Analysts: Enhance your analysis with a comprehensive, customizable biotech valuation model.
- Entrepreneurs: Understand how innovative biotech companies like Caribou are evaluated in the market.
What the Caribou Biosciences Template Contains
- Comprehensive DCF Model: Editable template featuring in-depth valuation calculations.
- Real-World Data: Caribou Biosciences’ historical and projected financials preloaded for analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Charts and tables providing clear, actionable results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.